NEOZAPIN

Orodispersible tablet, 200mg
RestrictedActive license

Active substance (INN)

clozapine

Pharmaceutical form

Pharmaceutical formOrodispersible tablet
Strength200mg
PackagingUkupno 50 oralnih disperzibilnih tableta u blisteru (5x10) u kartonskoj kutiji
ManufacturerSynthon BV, Netherlands
Therapeutic groupNervous system (N05AH02)
Marketing authorization holder"GLK PHARMA" DRUŠTVO SA OGRANIČENOM ODGOVORNOŠĆU, PODGORICA
Authorization dateFebruary 7, 2023

Analogs in Montenegro

8

Other medicines with the same active substance

CLOZAPIN SANDOZ®Restricted
Tablet, 25mgSalutas Pharma GmbH
CLOZAPIN SANDOZ®Restricted
Tablet, 100mgSalutas Pharma GmbH
CLOZAPINE REMEDICARx
Tablet, 25mgRemedica Ltd.
CLOZAPINE REMEDICARx
Tablet, 100mgRemedica Ltd.
LEPONEXRestricted
Tablet, 25mgNovartis Pharmaceuticals UK Ltd.
LEPONEX tabletaRestricted
, blisterNovartis Pharmaceuticals UK Ltd.
NEOZAPINRestricted
Orodispersible tablet, 25mgSynthon BV
NEOZAPINRestricted
Orodispersible tablet, 100mgSynthon BV
Data obtained from the official medicines registry of the CInMED Agency of Montenegro — cinmed.me ↗
Data updated: April 2026